NgeneBio Co., Ltd.

NgeneBio Co., Ltd. is a biotechnology company at the forefront of genetic testing and molecular diagnostics. Its primary function is to develop and provide innovative diagnostic solutions through Next Generation Sequencing (NGS) technologies. These technologies enable the precise analysis of genetic information, facilitating the diagnosis of various genetic disorders and diseases, including cancers and rare genetic conditions. NgeneBio's portfolio includes a range of diagnostic kits and software designed to enhance the accuracy and efficiency of genetic analysis, making significant contributions to the healthcare and medical research industries. Headquartered in South Korea, NgeneBio plays an important role in the healthcare market by transforming how genetic data is utilized, supporting personalized medicine, and improving clinical outcomes. Its impact is notable in sectors focused on advancing precision medicine and expanding access to reliable diagnostic tools, thus supporting scientific advancement and public health initiatives globally.